跳至主要内容
临床试验/NCT02326766
NCT02326766已完成3 期

Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects

Yonsei University0 个研究点目标入组 62 人开始时间: 2011年11月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
62
主要终点
changes from baselilne in blood pressure

研究概览

简要总结

This study evaluated effects of red ginseng consumption on blood pressure (BP) and fasting plasma metabolomes.

详细描述

A randomized, double-blind, placebo-controlled study was conducted on nonobese, nondiabetic and prehypertensive subjects. Over a 12 week test period, the red ginseng group (n=31) consumed 10 capsules (total 5g) daily containing red ginseng, while the placebo group (n=31) consumed the same product without red ginseng. Fasting plasma metabolomes were profiled using UPLC-LTQ-Orbitrap mass spectrometry.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •nondiabetic, nonobese and prehypertensive subjects with blood pressures ranging 120 - 139 mmHg (systolic) or 80-89 mmHg (diastolic) were enrolled in this study.

排除标准

  • •exclusion criteria included previous diagnosed clinical hypertension
  • •self-reported use of antihypertensive medication
  • •abnormal liver or renal function
  • •history of cardiovascular disease
  • •kidney disease
  • •thyroid or pituitary disease or any other serious life-threatening illness that required regular medical treatment
  • •we also excluded women who were pregnant, breast feeding or intending to become pregnant during the time of study.

研究组 & 干预措施

KRG

Experimental

5g Korea red ginseng (KRG)

干预措施: KRG (Dietary Supplement)

Placebo

Placebo Comparator

5 g placebo (corn starch)

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

changes from baselilne in blood pressure

时间窗: 12 week

次要结局

  • changes from baseline in plasma metabolites(12 week)

研究者

申办方类型
Other
责任方
Sponsor

相似试验